BE-RELACs-Trial: Biomarkers Explaining RELevance of ACute Rejections

Trial Profile

BE-RELACs-Trial: Biomarkers Explaining RELevance of ACute Rejections

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Belatacept (Primary) ; Ciclosporin
  • Indications Renal transplant rejection
  • Focus Biomarker; Pharmacodynamics
  • Acronyms BE-RELACs
  • Most Recent Events

    • 29 Jun 2016 Status changed from recruiting to discontinued.
    • 12 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top